GlassScriptPhysician profile
Polina Goldenberg
NPI 1720516974
$1,207.15
in general payments reported to CMS, 2019-2025
15 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.06 · 2022: $160 · 2023: $538 · 2024: $157 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $258.13 | 2022-2023 | Summit Doppler |
| Abbvie INC. | $182.11 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $135.46 | 2023 | Myfembree |
| Shield Therapeutics INC | $112.09 | 2023-2024 | Accrufer |
| Mayne Pharma Commercial LLC | $111.24 | 2023-2024 | |
| Baxter Healthcare | $102.17 | 2025 | Perclot |
| Hologic Sales and Service, LLC | $70.73 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Novo Nordisk INC | $52.65 | 2024-2025 | Wegovy |
| Pfizer INC. | $48.43 | 2023 | |
| Astellas Pharma US INC | $30.98 | 2025 | Veozah |
| Organon LLC | $26.56 | 2023-2024 | Nexplanon |
| Lilly USA, LLC | $24.59 | 2025 | Zepbound |
| Exeltis, USA INC. | $22.99 | 2023 | Slynd |
| Evofem Biosciences, INC. | $17.31 | 2021 | |
| Agile Therapeutics, INC. | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Polina Goldenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.